The evolution of opinion as to how to analyse the AB/BA cross-over trials is described by examining the recommendations of three key papers. The impact of these papers on the medical literature is analysed by looking at citation rates as a function of various factors. It is concluded that amongst practitioners there is a highly imperfect appreciation of the issues raised by the possibility of carryover. Copyright © 2004 John Wiley & Sons Ltd.
CITATION STYLE
Senn, S., & Lee, S. (2004). The analysis of the AB/BA cross-over trial in the medical literature. Pharmaceutical Statistics, 3(2), 123–131. https://doi.org/10.1002/pst.106
Mendeley helps you to discover research relevant for your work.